|
Volumn 375, Issue 9733, 2010, Pages 2278-
|
Anti-TNFα therapy-killing two birds with one stone?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADALIMUMAB;
GLIBENCLAMIDE;
HEMOGLOBIN A1C;
ISOPHANE INSULIN;
PENICILLAMINE;
PREDNISOLONE;
TUMOR NECROSIS FACTOR ALPHA ANTIBODY;
MONOCLONAL ANTIBODY;
TUMOR NECROSIS FACTOR ALPHA;
ADULT;
ARTICLE;
CASE REPORT;
DIABETES MELLITUS;
DISEASE CONTROL;
DRUG DOSE REDUCTION;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
GLUCOSE BLOOD LEVEL;
GLYCEMIC CONTROL;
HEMOGLOBIN BLOOD LEVEL;
HUMAN;
PRIORITY JOURNAL;
RHEUMATOID ARTHRITIS;
T LYMPHOCYTE;
TREATMENT RESPONSE;
DRUG ANTAGONISM;
INSULIN DEPENDENT DIABETES MELLITUS;
METABOLISM;
ADULT;
ANTIBODIES, MONOCLONAL;
ARTHRITIS, RHEUMATOID;
DIABETES MELLITUS, TYPE 1;
FEMALE;
HUMANS;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 77953829507
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(10)60394-7 Document Type: Article |
Times cited : (10)
|
References (4)
|